Profile
Richard Schwartz worked as Senior Director-Processing & Manufacturing Science at MedImmune Vaccines, Inc. from 2005 to 2008.
He then worked as Chief-Vaccine Production Program at Vaccine Research Center.
Later, he worked as Senior Vice President-Process Development at Synlogic, Inc. and as Senior Vice President-Technical Operations at Vaxart, Inc. In 2018-2019, he was Head-Technical Operations at CRISPR Therapeutics AG.
Dr. Schwartz received his undergraduate, graduate, and doctorate degrees from the University of Michigan.
Former positions of Richard Schwartz
Companies | Position | End |
---|---|---|
CRISPR THERAPEUTICS AG | Chief Tech/Sci/R&D Officer | 2019-09-30 |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Corporate Officer/Principal | 2008-04-30 |
Vaccine Research Center | Corporate Officer/Principal | - |
VAXART, INC. | Chief Tech/Sci/R&D Officer | - |
SYNLOGIC, INC. | Corporate Officer/Principal | - |
Training of Richard Schwartz
University of Michigan | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
CRISPR THERAPEUTICS AG | Health Technology |
SYNLOGIC, INC. | Health Technology |
VAXART, INC. | Health Technology |
Private companies | 2 |
---|---|
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
Vaccine Research Center |
- Stock Market
- Insiders
- Richard Schwartz